Spots Global Cancer Trial Database for spironolactone
Every month we try and update this database with for spironolactone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome | NCT00004311 | Acanthosis Nigr... Polycystic Ovar... | leuprolide acet... spironolactone | 0 Years - | Office of Rare Diseases (ORD) | |
| Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab | NCT01867294 | Advanced Malign... Dermatologic Co... | Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd... | 18 Years - | Academic and Community Cancer Research United | |
| Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess | NCT01422759 | Obesity Hyperandrogenem... Polycystic Ovar... | Spironolactone | 7 Years - 18 Years | University of Virginia | |
| Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess? | NCT04075149 | Polycystic Ovar... Puberty Disorde... Ovulation Disor... | Spironolactone | 13 Years - 19 Years | University of Virginia | |
| Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess | NCT01422759 | Obesity Hyperandrogenem... Polycystic Ovar... | Spironolactone | 7 Years - 18 Years | University of Virginia | |
| A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS) | NCT05394142 | Polycystic Ovar... | Placebo Pioglitazone Spironolactone Metformin | 12 Years - 23 Years | Fundació Sant Joan de Déu | |
| Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab | NCT01867294 | Advanced Malign... Dermatologic Co... | Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd... | 18 Years - | Academic and Community Cancer Research United | |
| Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) | NCT06005259 | Cardiotoxicity Neoplasms Chemotherapy Ef... Heart Failure | Spironolactone Placebo | 18 Years - | University of Sao Paulo | |
| Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism? | NCT04723862 | Hyperandrogenis... Polycystic Ovar... Puberty | Spironolactone Placebo | 10 Years - 17 Years | University of Virginia | |
| Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism? | NCT04723862 | Hyperandrogenis... Polycystic Ovar... Puberty | Spironolactone Placebo | 10 Years - 17 Years | University of Virginia | |
| Quadruple Immunotherapy for Neuroblastoma | NCT05754684 | Neuroblastoma R... | Natural killer ... Dinutuximab bet... Interleukin-2 Granulocyte-Mac... Spironolactone Naxitamab | - 18 Years | Hong Kong Children's Hospital | |
| Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients | NCT02531412 | Critically Ill Cancer | Spironolactone Placebo | 18 Years - 80 Years | Instituto Nacional de Cancerologia de Mexico | |
| Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment | NCT05797558 | Primary Hyperal... | Unilateral adre... Medical treatme... | 18 Years - 70 Years | Göteborg University | |
| A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS) | NCT05394142 | Polycystic Ovar... | Placebo Pioglitazone Spironolactone Metformin | 12 Years - 23 Years | Fundació Sant Joan de Déu | |
| Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment | NCT05797558 | Primary Hyperal... | Unilateral adre... Medical treatme... | 18 Years - 70 Years | Göteborg University | |
| Quadruple Immunotherapy for Neuroblastoma | NCT05754684 | Neuroblastoma R... | Natural killer ... Dinutuximab bet... Interleukin-2 Granulocyte-Mac... Spironolactone Naxitamab | - 18 Years | Hong Kong Children's Hospital | |
| Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess? | NCT04075149 | Polycystic Ovar... Puberty Disorde... Ovulation Disor... | Spironolactone | 13 Years - 19 Years | University of Virginia |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
